Oseaspre Consultants 2026: stake sale and ₹48 issue

What the filing says

Oseaspre Consultants Ltd disclosed that its promoters have entered into a share purchase agreement (SPA) to sell a controlling stake to Mr. Nimesh Sahadeo Singh. The company said it is not a party to the transaction, but it received a copy of the SPA on the date it was executed. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing places the transaction in the category of a change in control through a promoter-level transfer. Separately, the company’s board also approved a preferential issue, indicating that ownership and capital structure changes are unfolding in parallel. Both actions were recorded on September 18, 2026.

Promoters sign SPA to sell 73.52% stake

Under the SPA dated September 18, 2026, the promoters agreed to transfer 1,47,043 fully paid-up equity shares. This stake represents 73.52% of the company’s equity, as disclosed in the report. The total cash consideration mentioned for the deal is ₹70,58,064. Mr. Nimesh Sahadeo Singh is identified as the sole acquirer. The company clarified that it is not a signatory to the agreement, which is typical for off-market promoter transfers where the listed entity is only required to disclose material developments.

Who is selling and who is buying

The sellers named in the disclosure include Nowrosjee Wadia and Sons Limited, Tristar Charitable Foundation, Varnilam Investments and Trading Company Limited, Mr. Jehangir Nusli Wadia, and MSIL Investments Private Limited. Collectively, these entities hold the 1,47,043 shares proposed to be sold under the SPA. The acquirer is Mr. Nimesh Sahadeo Singh, and the filing lists him as the only buyer under the agreement. The transaction is structured as a cash deal, with a stated consideration amount in rupees. The filing does not indicate that any other acquirers or co-investors are involved.

Open offer requirement under takeover rules

The disclosure states that the acquirer is required to make an open offer to public shareholders in accordance with the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company also noted that the cash consideration is subject to the successful completion of this open offer. This condition links the completion of the promoter-level transfer to the mandatory process for acquiring shares from public shareholders when control changes hands. The filing, as presented, does not provide open offer price or timelines beyond confirming the requirement.

Preferential issue approved at ₹48 per share

On the same date, September 18, 2026, Oseaspre Consultants’ board approved a preferential issue of up to 5,00,000 equity shares at ₹48 per share. The company stated that the preferential issue is aimed at non-promoter public investors. Any such allotment would be subject to shareholder approval. The EGM for shareholder approval is scheduled for October 30, 2026. The preferential issue proposal is separate from the SPA, but it is relevant because it can change shareholding percentages post-allotment.

Authorised capital increase to support the issuance

Alongside the preferential issue, the company approved an increase in authorised share capital from ₹20,00,000 to ₹70,00,000. The filing describes this as raising the number of equity shares from 2,00,000 to 7,00,000, with a face value of ₹10 per share. This step is procedural and intended to ensure the company has sufficient authorised capital headroom to issue new equity. The disclosed face value is ₹10 per share. The company’s board decision requires shareholder approval as part of the broader process.

Proposed allottees and post-issue holding snapshot

The filing identifies Mr. Nimesh Sahadeo Singh as the largest proposed allottee under the preferential issue. He is proposed to receive 3,25,000 shares, with a stated post-issue holding of 46.43%. The document also lists other proposed non-promoter public allottees including Jaya Prem Rajdev and Pramesh Wealth Private Limited, with share counts and post-issue percentages provided for those entries. Additional names mentioned include Modi Jaymin Piyushbhai, Vanita Pravin Patel, Mittal Nilesh Sangani, and Neha Manish Shanghvi, but the excerpted details do not provide share numbers for them.

Stock and valuation datapoints mentioned

The provided market snapshot lists Oseaspre Consultants at ₹17.95 with 0.0 (0.0%) change at the time of that screen. It also shows a market capitalisation of ₹0.36 crore. Other datapoints displayed include a P/E ratio (TTM) of -2.37, an industry P/E of 17.77, book value of 29.87, and debt to equity of 0.00. The BSE symbol shown is 509782. These figures are presented as part of the information accompanying the news and are not part of the company’s board resolutions.

Why the two actions matter for shareholders

The SPA signals a potential change in control because it involves a transfer of 73.52% of the equity to a single acquirer. The filing also makes it explicit that an open offer under the takeover regulations is required, which is a defined process for public shareholders. Separately, the preferential issue involves issuing new shares at ₹48, subject to shareholder approval at the October 30, 2026 EGM. When a company simultaneously discloses a control transaction and a fresh issue proposal, shareholders typically track the sequencing of regulatory steps, EGM outcomes, and subsequent disclosures. In this case, the company’s own disclosure emphasises that it is not a party to the SPA, while the preferential issue is a board-approved corporate action requiring shareholder consent.

What to watch next

Based on the information disclosed, the next formal milestone is the extraordinary general meeting scheduled for October 30, 2026 for shareholder approval related to the preferential issue and the authorised capital increase. In parallel, the open offer process under SEBI (SAST) Regulations, 2011 will need to proceed as required for the SPA-linked change in control. Investors will likely rely on subsequent regulatory filings for details on open offer terms and the final outcome of the preferential allotment approvals. The company’s future disclosures under SEBI LODR will be the primary source for confirmed updates.